Esmolol

Generic Name
Esmolol
Brand Names
Brevibloc
Drug Type
Small Molecule
Chemical Formula
C16H25NO4
CAS Number
81147-92-4
Unique Ingredient Identifier
MDY902UXSR
Background

Esmolol, commonly marketed under the trade name Brevibloc, is a cardioselective beta-1 receptor blocker. It has a rapid onset but short duration of action without causing significant intrinsic sympathomimetic or membrane stabilizing activities at recommended therapeutic doses. It works by blocking beta-adrenergic receptors in the heart, which leads to decrea...

Indication

For the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention.

Associated Conditions
Hypertension, Tachycardia, Abnormal ventricular rate, Heart rate abnormal
Associated Therapies
-

Esmolol Infusion in Patients Undergoing Craniotomy

First Posted Date
2015-05-27
Last Posted Date
2015-07-08
Lead Sponsor
George Papanicolaou Hospital
Target Recruit Count
50
Registration Number
NCT02455440
Locations
🇬🇷

George Papanikolaou General Hospital, Thessaloniki, Greece

Esmolol to Treat the Hemodynamic Effects of Septic Shock

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2015-02-24
Last Posted Date
2021-06-28
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
40
Registration Number
NCT02369900
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients

Completed
Conditions
Interventions
First Posted Date
2014-07-14
Last Posted Date
2015-08-07
Lead Sponsor
University of Roma La Sapienza
Target Recruit Count
45
Registration Number
NCT02188888
Locations
🇮🇹

Department of Anesthesiology and Intensive care of the University of Rome La Sapienza, Rome, Italy

Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction

First Posted Date
2014-03-28
Last Posted Date
2017-10-09
Lead Sponsor
Ming-He Huang
Registration Number
NCT02098629
Locations
🇨🇳

Yuebei People's Hospital, Shaoguan, Guangdong, China

Esmolol Effects on Heart and Inflammation in Septic Shock

Phase 2
Conditions
Interventions
First Posted Date
2014-02-21
Last Posted Date
2016-01-28
Lead Sponsor
Central Hospital, Nancy, France
Target Recruit Count
25
Registration Number
NCT02068287
Locations
🇫🇷

CHU de Nancy, Nancy, France

The Effects of the Drugs Used in Hypotensive Anaesthesia on Cochlea

First Posted Date
2014-02-13
Last Posted Date
2014-11-10
Lead Sponsor
TC Erciyes University
Target Recruit Count
47
Registration Number
NCT02062333
Locations
🇹🇷

Kayseri Education and Research Hospital, Kayseri, Turkey

Nicardipine vs Esmolol Craniotomy Emergence

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-09-27
Last Posted Date
2014-08-29
Lead Sponsor
Northwestern University
Target Recruit Count
40
Registration Number
NCT01951950
Locations
🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

Esmolol Pretreatment on Pain During Injection of Propofol

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-06-25
Last Posted Date
2016-02-08
Lead Sponsor
Kyungpook National University Hospital
Target Recruit Count
120
Registration Number
NCT01885364
Locations
🇰🇷

Kyungpook National University Hospital, Daegu, Korea, Republic of

Effect of Esmolol on Pain Due to Rocuronium

First Posted Date
2013-04-05
Last Posted Date
2019-10-04
Lead Sponsor
Ankara Diskapi Training and Research Hospital
Target Recruit Count
90
Registration Number
NCT01824758
Locations
🇹🇷

Diskapi Teaching and Research Hospital, Ankara, Altindag, Turkey

© Copyright 2024. All Rights Reserved by MedPath